![]() |
市場調查報告書
商品編碼
1439664
功能性電刺激 (FES) 設備 - 全球市場回顧、競爭格局、市場預測 (2030)Functional Electrical Stimulation (FES) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
在 2024 年至 2030 年的預測期內,全球功能性電刺激 (FES) 設備市場規模預計將以 8.2% 的複合年增長率成長。 功能性電刺激 (FES) 設備的需求增加主要是由於全球肌肉骨骼疾病的盛行率不斷上升。 此外,疼痛管理治療和產品開發中的技術創新的重要性預計將在未來幾年推動 FES 市場的發展。
功能性電刺激 (FES) 設備市場動態:
由於全世界人民的肌肉骨骼疾病負擔日益增加,功能性電刺激 (FES) 設備市場目前正在蓬勃發展。 這是因為FES裝置刺激肌肉活動性,增強肌肉活動性,減少肌肉痙攣,有利於肌肉活動的啟動,同時也提供運動記憶。 例如,根據世界衛生組織(WHO)2023年發佈的數據,2020年全球共有17.1億人患有肌肉骨骼疾病。
此外,根據 Gov.UK (2020) 的數據,2020 年,英國 18 歲及以上患有肌肉骨骼疾病的人報告長期背痛或長期關節痛的比例為率為18.5%。 男性報告長期肌肉骨骼問題的可能性也低於女性(分別為 15.9% 和 20.9%)。 世界其他國家也可能出現類似的趨勢,增加對 FES 設備的需求,並預測全球 FES 市場的擴張。
此外,主要製造商積極開發FES設備以為目標族群提供突破性復健護理的重大市場擴張活動也正在推動未來幾年FES市場的潛在成長,這可能是一個因素。 例如,2017 年 12 月,Ekso Bionics 與 HASOMED 合作推出了針對 EksoGT™ 外骨骼的功能性電刺激 (FES)。
因此,上述所有因素的相互作用預計將在預測期內推動全球 FES 設備市場的發展。
然而,與功能性電刺激 (FES) 設備相關的風險以及這些設備的高成本可能會阻礙市場成長。
史無前例的 COVID-19 爆發對功能性電刺激 (FES) 設備市場產生了重大影響。 在 COVID-19 大流行期間,實施了封鎖規定,導致患者就診次數減少,所有其他外科手術暫時停止,並且對 COVID-19 患者給予更多關注。我做到了。 然而,隨著封鎖規定的放鬆和生產設施的重新開放,FES 設備市場正在恢復正常。
功能性電刺激 (FES) 設備細分市場分析:
在功能性電刺激 (FES) 設備的適應症領域中,神經系統疾病領域預計將在預測期內佔主要佔有率。 多發性硬化症和中風等神經系統疾病可能會增加對 FES 設備的需求。 這是因為 FES 設備被用作一種治療方法,透過施加溫和的電脈衝來刺激肌肉。 對於多發性硬化症患者,FES 提供改善肌肉運動的外部訊號。 因此,由於全球目標人群不斷增加,FES 設備的市場可能會擴大。 例如,根據多發性硬化症國際聯合會 2020 年發佈的數據,全球約有 280 萬人患有多發性硬化症。
此外,公司和研究型大學為調查FES設備在中風復健中的有效性而進行的各種研發和臨床試驗也可能推動FES設備市場快速成長。 例如,Intento SA於2019年啟動了一項臨床試驗,研究 "自我調節功能性電刺激(SM-FES)對患有重度和中度上肢癱瘓的慢性中風患者的療效" 。 該試驗預計將於 2022 年 12 月完成。
本報告提供了全球功能性電刺激 (FES) 設備市場的研究和分析,包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。
Functional Electrical Stimulation (FES) Devices Market By Product Type (Wired Devices And Wireless Devices), By Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), by geography, is projected to grow at a noteworthy CAGR forecast till 2030 owing to the rising prevalence of musculoskeletal disorders and technological innovation in product development
The Global Functional Electrical Stimulation Devices Market will grow at a CAGR of 8.2% during the forecast period from 2024 to 2030. The increase in demand for Functional Electrical Stimulation (FES) Devices is primarily due to the rising prevalence of musculoskeletal disorders across the globe. Moreover, the rising importance of pain management therapies and technological innovation in product development is anticipated to fuel the FES market in the upcoming years.
Functional Electrical Stimulation (FES) Devices Market Dynamics:
The market for functional electrical stimulation (FES) devices is gaining propulsion at present owing to the growing burden of musculoskeletal disorders among the population across the globe. This is because FES devices stimulate muscles mobility and strengthen muscle activity, reduce muscle spasticity, facilitate initiation of muscle activity, and also provide a memory of movement. For instance, as per the data published by the World Health Organization (WHO) in the year 2023, a total of 1.71 billion people were suffering from musculoskeletal conditions across the world in the year 2020.
In addition, as per the Gov.UK 2020, in the year 2020, the percentage of people aged 18 and above who reported musculoskeletal condition, either long-term back pain or long-term joint pain was reported to be 18.5% in the United Kingdom. Also, the data mentioned that males remained less likely to report a long-term musculoskeletal problem than females (15.9% and 20.9% respectively) in the United Kingdom in the year 2020. Similar trends are likely to be observed in other countries around the world which are expected to increase the demand for FES devices thereby augmenting the global FES market.
Moreover, key market expansion activities by the key manufacturers actively developing FES devices to provide breakthrough rehabilitative care among the target population could also be a potential factor contributing to the growth of the FES market during the upcoming years. For instance, in December 2017, Ekso Bionics® partnered with HASOMED to launch functional electrical stimulation (FES) for the EksoGT(TM) Exoskeleton.
Thus, the interplay of all the above-mentioned factors is expected to boost the global FES devices market during the forecasted period.
However, the risk associated with functional electrical stimulation devices as well as the high cost of these devices is likely to impede the market growth.
The unprecedented COVID-19 outbreak had a profound impact on the market for functional electrical stimulation (FES) devices. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patient visits and all other surgical procedures were temporarily paused, giving more attention to the COVID-19 inflicted patients. However, after the relaxation given in terms of lockdown restrictions and the re-opening of manufacturing facilities, the FES devices market is regaining normalcy.
Functional Electrical Stimulation (FES) Devices Market Segment Analysis:
Functional Electrical Stimulation (FES) Devices Market By Product Type (Wired Devices and Wireless Devices), By Indication (Neurological Disorders, Pain Management, Musculoskeletal Disorders, and Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Functional Electrical Stimulation (FES) Devices indication segment, the neurological disorders segment is anticipated to hold a significant share during the forecasted period. Neurological disorders such as multiple sclerosis, strokes, among others are likely to increase the demand for FES devices. This is because FES devices are used as a treatment that involves the application of mild electrical pulses to stimulate muscles. In patients with multiple sclerosis, FES provides an external signal that makes muscle movement better. Thus, the rising target population across the globe is likely to augment the market for FES devices. For instance, according to the data published by the MS International Federation in the year 2020, approximately 2.8 million people were living with MS worldwide.
Moreover, various R&D and clinical trials conducted by companies and research universities to study the effectiveness of FES devices in stroke rehabilitation could also upsurge the market for FES devices. For instance, Intento SA, initiated a clinical trial to study the efficacy of "Self-modulated Functional Electrical Stimulation in Chronic Stroke Patients with Severe and Moderate Upper Limb Paresis (SM-FES)" in the year 2019. The trial is expected to get complete by December 2022.
Thus, the above-mentioned factors are expected to increase the demand for FES devices for neurological disorders in the forthcoming years.
North America To Dominate the Functional Electrical Stimulation (FES) Devices Market:
Among all the regions, North America is anticipated to dominate the Functional Electrical Stimulation (FES) Devices market during the forecasted period. This is owing to the rising prevalence of the targeted population such as stroke, cerebral palsy, and musculoskeletal disorders, among others. Additionally, the rising obese population in the region could also increase the risk of developing musculoskeletal disorders as well as stroke among the population, leading to an increased demand for FES devices in the upcoming years. Moreover, the presence of key players in the region is one of the factors projected to drive the regional FES market.
Further, in the US, as per the data provided by the U.S Bureau of Labor Statistics 2018, about 272,780 people were suffering from musculoskeletal disorders in the United States private sector. Thus, owing to a rise in musculoskeletal disorders, there will be an increase in the demand for functional electrical stimulation leading to an overall rise in the functional electrical stimulation market.
Moreover, growing cases of chronic pain among the US population could also raise the demand for FES devices thereby bolstering the market. For instance, as per the data published by the Centers for Disease Control and Prevention (CDC) in the year 2020, approximately, 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities in the US in the year 2019.
In addition, certain strategies like merger & acquisition, getting FDA approval, and new product launches by the manufacturers to maintain their position in the market will also contribute to the regional market growth of FES devices. For instance, on September 21, 2020, Medline Industries, LP received FDA approval for Medline DeNovo 4Pro Electrical Stimulation Device intended to be used for muscle stimulation for urinary incontinence treatment, pain management, muscle strengthening, and training. The device is a TENS (Transcutaneous Electrical Nerve Stimulator), ETS (Electrical Muscle Stimulator), and NMES (Neuromuscular Electrical Stimulator also known as STIM) including FES (Functional Electrical Stimulation) with EMG biofeedback.
Hence, all the aforementioned factors are likely to spur the regional market for FES devices in the forthcoming years.
Functional Electrical Stimulation (FES) Devices Market Key Companies:
Some of the key market players operating in the Functional Electrical Stimulation Devices market include HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.
Recent Developmental Activities in the Functional Electrical Stimulation Devices Market:
On October 29, 2020, g.tec medical engineering GmbH received FDA approval for g.Estim FES, neuromuscular electronic stimulator indicated for use under medical supervision for adjunctive therapy in the treatment of medical diseases and conditions.
On March 04, 2020, Bioness Inc. received FDA approval for L100 Go System intended to provide ankle dorsiflexion in adults with foot drop or muscle weakness related to upper motor neuron disease/injury (e.g., stroke, damage to pathways to the spinal cord).
Key Takeaways from the Functional Electrical Stimulation Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Functional Electrical Stimulation (FES) Devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Functional Electrical Stimulation (FES) Devices Market.
Various opportunities available for the other competitor in the Functional Electrical Stimulation (FES) Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Functional Electrical Stimulation (FES) Devices market growth in the coming future?
Target Audience who can be benefited from the Functional Electrical Stimulation (FES) Devices Market Report Study
Functional Electrical Stimulation (FES) Devices providers
Research organizations and consulting companies
Functional Electrical Stimulation (FES) Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Functional Electrical Stimulation (FES) Devices
Various End-users who want to know more about the Functional Electrical Stimulation (FES) Devices Market and the latest technological developments in the Functional Electrical Stimulation (FES) Devices market.
Frequently Asked Questions for the Functional Electrical Stimulation (FES) Devices Market:
Functional electrical stimulation (FES) is a treatment method in which low-level electrical impulses are applied to nerves or muscles to improve or restore muscle function.
The Global Functional Electrical Stimulation Devices Market will grow at a CAGR of 8.2% during the forecast period from 2024 to 2030.
The major factor driving the demand for Functional Electrical Stimulation (FES) Devices is the rising prevalence of musculoskeletal disorders across the globe. Moreover, the rising importance of pain management therapies and technological innovation in product development is anticipated to fuel the FES market in the upcoming years.
Some of the key market players operating in the Functional Electrical Stimulation (FES) Devices market include HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.
Among all the regions, North America is anticipated to dominate the Functional Electrical Stimulation (FES) Devices market during the forecasted period. This is owing to the rising prevalence of the targeted population such as stroke, cerebral palsy, and musculoskeletal disorders, among others. Additionally, the rising obese population in the region could also increase the risk of developing musculoskeletal disorders as well as stroke among the population, leading to an increased demand for FES devices in the upcoming years. Moreover, the presence of key players in the region is one of the factors projected to drive the regional FES market.